Public Cloud Service
Public Cloud Service market is segmented by region (country), players, by Type and by Application ... Read More
Global and United States Psoriasis Therapeutics Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Psoriasis Therapeutics Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Psoriasis Therapeutics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Psoriasis Therapeutics Market Size for the Year 2017-2028
1.2.2 Global Psoriasis Therapeutics Market Size for the Year 2017-2028
1.3 Psoriasis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Psoriasis Therapeutics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Psoriasis Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Psoriasis Therapeutics Market Dynamics
1.4.1 Psoriasis Therapeutics Industry Trends
1.4.2 Psoriasis Therapeutics Market Drivers
1.4.3 Psoriasis Therapeutics Market Challenges
1.4.4 Psoriasis Therapeutics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Psoriasis Therapeutics by Type
2.1 Psoriasis Therapeutics Market Segment by Type
2.1.1 TNF Inhibitors
2.1.2 PDE4 Inhibitors
2.1.3 Interleukin Blockers
2.1.4 Others
2.2 Global Psoriasis Therapeutics Market Size by Type (2017, 2022 & 2028)
2.3 Global Psoriasis Therapeutics Market Size by Type (2017-2028)
2.4 United States Psoriasis Therapeutics Market Size by Type (2017, 2022 & 2028)
2.5 United States Psoriasis Therapeutics Market Size by Type (2017-2028)
3 Psoriasis Therapeutics by Application
3.1 Psoriasis Therapeutics Market Segment by Application
3.1.1 Oral
3.1.2 Parenteral
3.1.3 Topical
3.2 Global Psoriasis Therapeutics Market Size by Application (2017, 2022 & 2028)
3.3 Global Psoriasis Therapeutics Market Size by Application (2017-2028)
3.4 United States Psoriasis Therapeutics Market Size by Application (2017, 2022 & 2028)
3.5 United States Psoriasis Therapeutics Market Size by Application (2017-2028)
4 Global Psoriasis Therapeutics Competitor Landscape by Company
4.1 Global Psoriasis Therapeutics Market Size by Company
4.1.1 Top Global Psoriasis Therapeutics Companies Ranked by Revenue (2021)
4.1.2 Global Psoriasis Therapeutics Revenue by Player (2017-2022)
4.2 Global Psoriasis Therapeutics Concentration Ratio (CR)
4.2.1 Psoriasis Therapeutics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Psoriasis Therapeutics in 2021
4.2.3 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Psoriasis Therapeutics Headquarters, Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Psoriasis Therapeutics Headquarters and Area Served
4.3.2 Global Psoriasis Therapeutics Companies Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Psoriasis Therapeutics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Psoriasis Therapeutics Market Size by Company
4.5.1 Top Psoriasis Therapeutics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Psoriasis Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Psoriasis Therapeutics Market Size by Region
5.1 Global Psoriasis Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Psoriasis Therapeutics Market Size by Region (2017-2028)
5.2.1 Global Psoriasis Therapeutics Market Size by Region: 2017-2022
5.2.2 Global Psoriasis Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Psoriasis Therapeutics Market Size YoY Growth 2017-2028
6.1.2 North America Psoriasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Psoriasis Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Psoriasis Therapeutics Market Size YoY Growth 2017-2028
6.3.2 Europe Psoriasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Psoriasis Therapeutics Market Size YoY Growth 2017-2028
6.4.2 Latin America Psoriasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Psoriasis Therapeutics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Psoriasis Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Astellas Pharma Inc.
7.1.1 Astellas Pharma Inc. Company Details
7.1.2 Astellas Pharma Inc. Business Overview
7.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
7.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
7.1.5 Astellas Pharma Inc. Recent Development
7.2 AstraZeneca plc
7.2.1 AstraZeneca plc Company Details
7.2.2 AstraZeneca plc Business Overview
7.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
7.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2017-2022)
7.2.5 AstraZeneca plc Recent Development
7.3 Boehringer Ingelheim GmbH
7.3.1 Boehringer Ingelheim GmbH Company Details
7.3.2 Boehringer Ingelheim GmbH Business Overview
7.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
7.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2017-2022)
7.3.5 Boehringer Ingelheim GmbH Recent Development
7.4 F. Hofffmann-La Roche
7.4.1 F. Hofffmann-La Roche Company Details
7.4.2 F. Hofffmann-La Roche Business Overview
7.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
7.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2017-2022)
7.4.5 F. Hofffmann-La Roche Recent Development
7.5 GlaxoSmithKline plc
7.5.1 GlaxoSmithKline plc Company Details
7.5.2 GlaxoSmithKline plc Business Overview
7.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
7.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2017-2022)
7.5.5 GlaxoSmithKline plc Recent Development
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Company Details
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
7.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
7.6.5 Merck & Co., Inc. Recent Development
7.7 Valeant Pharmaceuticals International, Inc.
7.7.1 Valeant Pharmaceuticals International, Inc. Company Details
7.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
7.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
7.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
7.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
7.8 Biocon Limited
7.8.1 Biocon Limited Company Details
7.8.2 Biocon Limited Business Overview
7.8.3 Biocon Limited Psoriasis Therapeutics Introduction
7.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2017-2022)
7.8.5 Biocon Limited Recent Development
7.9 Eli Lilly and Company
7.9.1 Eli Lilly and Company Company Details
7.9.2 Eli Lilly and Company Business Overview
7.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
7.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2017-2022)
7.9.5 Eli Lilly and Company Recent Development
7.10 G & W Laboratories Inc.
7.10.1 G & W Laboratories Inc. Company Details
7.10.2 G & W Laboratories Inc. Business Overview
7.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
7.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2017-2022)
7.10.5 G & W Laboratories Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Psoriasis Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Psoriasis Therapeutics Market Trends
Table 3. Psoriasis Therapeutics Market Drivers
Table 4. Psoriasis Therapeutics Market Challenges
Table 5. Psoriasis Therapeutics Market Restraints
Table 6. Global Psoriasis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Psoriasis Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Psoriasis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Psoriasis Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Psoriasis Therapeutics Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Psoriasis Therapeutics Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Psoriasis Therapeutics Revenue Share by Player, 2017-2022
Table 13. Global Psoriasis Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Psoriasis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2021)
Table 15. Top Players of Psoriasis Therapeutics in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Psoriasis Therapeutics Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Psoriasis Therapeutics Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Psoriasis Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Psoriasis Therapeutics Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Psoriasis Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Psoriasis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Psoriasis Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Psoriasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Psoriasis Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Psoriasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Psoriasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Psoriasis Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Astellas Pharma Inc. Company Details
Table 31. Astellas Pharma Inc. Business Overview
Table 32. Astellas Pharma Inc. Psoriasis Therapeutics Product
Table 33. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 34. Astellas Pharma Inc. Recent Development
Table 35. AstraZeneca plc Company Details
Table 36. AstraZeneca plc Business Overview
Table 37. AstraZeneca plc Psoriasis Therapeutics Product
Table 38. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 39. AstraZeneca plc Recent Development
Table 40. Boehringer Ingelheim GmbH Company Details
Table 41. Boehringer Ingelheim GmbH Business Overview
Table 42. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product
Table 43. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 44. Boehringer Ingelheim GmbH Recent Development
Table 45. F. Hofffmann-La Roche Company Details
Table 46. F. Hofffmann-La Roche Business Overview
Table 47. F. Hofffmann-La Roche Psoriasis Therapeutics Product
Table 48. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 49. F. Hofffmann-La Roche Recent Development
Table 50. GlaxoSmithKline plc Company Details
Table 51. GlaxoSmithKline plc Business Overview
Table 52. GlaxoSmithKline plc Psoriasis Therapeutics Product
Table 53. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 54. GlaxoSmithKline plc Recent Development
Table 55. Merck & Co., Inc. Company Details
Table 56. Merck & Co., Inc. Business Overview
Table 57. Merck & Co., Inc. Psoriasis Therapeutics Product
Table 58. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 59. Merck & Co., Inc. Recent Development
Table 60. Valeant Pharmaceuticals International, Inc. Company Details
Table 61. Valeant Pharmaceuticals International, Inc. Business Overview
Table 62. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product
Table 63. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 64. Valeant Pharmaceuticals International, Inc. Recent Development
Table 65. Biocon Limited Company Details
Table 66. Biocon Limited Business Overview
Table 67. Biocon Limited Psoriasis Therapeutics Product
Table 68. Biocon Limited Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Biocon Limited Recent Development
Table 70. Eli Lilly and Company Company Details
Table 71. Eli Lilly and Company Business Overview
Table 72. Eli Lilly and Company Psoriasis Therapeutics Product
Table 73. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Eli Lilly and Company Recent Development
Table 75. G & W Laboratories Inc. Company Details
Table 76. G & W Laboratories Inc. Business Overview
Table 77. G & W Laboratories Inc. Psoriasis Therapeutics Product
Table 78. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2017-2022) & (US$ Million)
Table 79. G & W Laboratories Inc. Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Psoriasis Therapeutics Product Picture
Figure 2. Global Psoriasis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Psoriasis Therapeutics Market Size 2017-2028 (US$ Million)
Figure 4. United States Psoriasis Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Psoriasis Therapeutics Market Size 2017-2028 (US$ Million)
Figure 6. United States Psoriasis Therapeutics Market Share in Global 2017-2028
Figure 7. Psoriasis Therapeutics Report Years Considered
Figure 8. Product Picture of TNF Inhibitors
Figure 9. Product Picture of PDE4 Inhibitors
Figure 10. Product Picture of Interleukin Blockers
Figure 11. Product Picture of Others
Figure 12. Global Psoriasis Therapeutics Market Share by Type in 2022 & 2028
Figure 13. Global Psoriasis Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Psoriasis Therapeutics Market Share by Type (2017-2028)
Figure 15. United States Psoriasis Therapeutics Market Share by Type in 2022 & 2028
Figure 16. United States Psoriasis Therapeutics Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Psoriasis Therapeutics Market Share by Type (2017-2028)
Figure 18. Product Picture of Oral
Figure 19. Product Picture of Parenteral
Figure 20. Product Picture of Topical
Figure 21. Global Psoriasis Therapeutics Market Share by Application in 2022 & 2028
Figure 22. Global Psoriasis Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global Psoriasis Therapeutics Market Share by Application (2017-2028)
Figure 24. United States Psoriasis Therapeutics Market Share by Application in 2022 & 2028
Figure 25. United States Psoriasis Therapeutics Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States Psoriasis Therapeutics Market Share by Application (2017-2028)
Figure 27. North America Psoriasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe Psoriasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Psoriasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America Psoriasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Psoriasis Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E Psoriasis Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 56. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 57. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 58. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 59. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 60. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 61. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 62. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 64. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Astellas Pharma Inc. AstraZeneca plc Boehringer Ingelheim GmbH F. Hofffmann-La Roche GlaxoSmithKline plc Merck & Co., Inc. Valeant Pharmaceuticals International, Inc. Biocon Limited Eli Lilly and Company G & W Laboratories Inc.